CVS Health's third-quarter earnings fell short of expectations, with revenue slightly exceeding forecasts. Analysts expect a 5.1% revenue increase and a 43% surge in per-share earnings by 2025. Despite the decline in earnings estimates, the consensus price target remains stable.